GPT and hepatocellular carcinoma: The presence of resistant HBV mutations usually causes a virological breakthrough (any increase in serum HBV DNA) as well as a clinical breakthrough manifested by acute exacerbations of disease (ALT elevations), faster progression to liver failure and liver transplants, and a higher risk of HCC and death.16, 17